Portal de Periódicos da CAPES

Heart failure entails significant changes in human nucleocytoplasmic transport gene expression

2013; Elsevier BV; Volume: 168; Issue: 3 Linguagem: Inglês

10.1016/j.ijcard.2013.03.192

1874-1754

Maria Micaela Molina‐Navarro, Esther Roselló‐Lletí, Estefanía Tarazón, Ana Ortega, Dolors Sánchez-Izquierdo, Francisca Lago, José Ramón González‐Juanatey, Pablo García‐Pavía, Antonio Salvador, José Montero, Manuel Portolés, Miguel Rivera,

Viral Infections and Immunology Research

Heart failure (HF) induces alterations in nucleocytoplasmic transport, which is essential to the cardiomyocyte biology. The objective of this study was to analyze the changes in gene expression in human HF, particularly focusing on nucleocytoplasmic transport-related genes.29 RNA heart samples from dilated cardiomyopathy (DCM, n = 12) and ischemic cardiomyopathy (ICM, n = 12) patients undergoing heart transplantation and control donors (CNT, n = 5) were extracted to perform a microarray profiling using Affymetrix Human Gene® 1.0 ST arrays. We focused on the study of 5 nucleocytoplasmic transport-related genes, since this functional category has not previously been studied in HF. XPO1, GABPB2, and RANBP17 were upregulated, while KALRN was downregulated in both DCM and ICM, and XPO5 only in DCM. Validation of the results by RT-qPCR increasing the total heart samples up to 41 showed a high degree of consistency with microarray results. Moreover, we observed a strong relationship between the XPO1 mRNA and robust left ventricular function parameters in ICM: left ventricular end-systolic (r = 0.81, p<0.0001) and end-diastolic diameters (r = 0.80, p<0.0001), and ejection fraction (r = -0.57, p<0.05).We show that the expression of nucleocytoplasmic transport-related genes is altered in HF. Furthermore, XPO1 mRNA level is closely related with robust left ventricular function parameters in ICM patients. These changes may help to distinguish DCM and ICM in HF at the level of the transcriptome and provide a base for novel therapeutic approaches.